Cargando…

Alterations in CD8(+) Tregs, CD56(+) Natural Killer Cells and IL-10 Are Associated With Invasiveness of Nonfunctioning Pituitary Adenomas (NFPAs)

Invasive nonfunctioning pituitary adenomas (NFPAs) grow rapidly and the mechanisms are unclear. Among many complex mechanisms, the role of immunity in the development of NFPAs has not been fully explored. Here, we analyzed the clinical features 146 NFPA patients who underwent trans-sphenoidal surger...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Xinmei, Xu, Jiong, Wu, Yueyue, Sheng, Li, Li, Yue, Zha, Bingbing, Sun, Tiange, Yang, Ju, Zang, Shufei, Liu, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Society Journal Archive
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262195/ https://www.ncbi.nlm.nih.gov/pubmed/34257554 http://dx.doi.org/10.3389/pore.2021.598887

Ejemplares similares

Association of High Prolactin Level on Postoperative Day 1 and Tumor Invasion with Female Gonadal Dysfunction After Trans-Sphenoidal Surgery of Pituitary Adenomas
por: Huang, Xinmei, et al.
Publicado: (2018)

Overexpression of CD44v8-10 in Colon Polyps—A Possible Key to Early Diagnosis
por: Dastych, Milan, et al.
Publicado: (2021)

Immunohistochemical Profile of Nonfunctioning Pituitary Adenomas
por: Solovey, Mariana, et al.
Publicado: (2021)

Nonfunctioning giant pituitary adenomas: Invasiveness and recurrence
por: Landeiro, José Alberto, et al.
Publicado: (2015)

Coexistence of arteriovenous malformation with nonfunctioning pituitary adenoma
por: Yılmaz, Baran, et al.
Publicado: (2015)

Distinct Signatures in the Receptor Repertoire Discriminate CD56bright and CD56dim Natural Killer Cells
por: Schwane, Vera, et al.
Publicado: (2020)

Integrated analysis of competitive endogenous ribose nucleic acids (ceRNAs)-related regulatory networks in invasive and non-invasive non-functioning pituitary adenomas (NFPAs)
por: Liu, Jiangtao, et al.
Publicado: (2022)

Evaluation of CD56(dim) and CD56(bright) natural killer cells in peripheral blood of women with IVF failures
por: Mardanian, Farahnaz, et al.
Publicado: (2015)

Heterogeneity analysis of the proteomes in clinically nonfunctional pituitary adenomas
por: Zhan, Xianquan, et al.
Publicado: (2014)

Nonfunctioning Pituitary Adenoma That Changed to a Functional Gonadotropinoma
por: Andino-Ríos, Gerson Geovany, et al.
Publicado: (2018)

Methylome Analysis in Nonfunctioning and GH-Secreting Pituitary Adenomas
por: Giuffrida, Giuseppe, et al.
Publicado: (2022)

Diagnosis and Treatment of Nonfunctioning Pituitary Adenomas with Thyroid Disorders
por: Wang, Xu, et al.
Publicado: (2023)

Incidental versus symptomatic nonfunctioning pituitary adenomas: Are they different?
por: Guerreiro, Vanessa, et al.
Publicado: (2023)

Clinical evaluations of pituitary apoplexy in incidental nonfunctional pituitary adenomas
por: Takeshita, Kaori, et al.
Publicado: (2022)

Impact of polysialylated CD56 on natural killer cell cytotoxicity
por: Moebius, Jeannette M, et al.
Publicado: (2007)

MicroRNA profiling of CD3(+)CD56(+) cytokine-induced killer cells
por: Wang, Wenju, et al.
Publicado: (2015)

Human Natural Killer Cell Maturation Defect Supports In Vivo CD56(bright) to CD56(dim) Lineage Development
por: Domaica, Carolina Inés, et al.
Publicado: (2012)

Increased neutrophil count Is associated with the development of chronic kidney disease in patients with diabetes
por: Zhang, Rui, et al.
Publicado: (2022)

CD56(dim)CD16(dim) Natural Killer (NK) Cells: The Forgotten Population
por: Zimmer, Jacques
Publicado: (2020)

CD56(bright) natural killer cells preferentially kill proliferating CD4(+) T cells
por: Lee, Mercede, et al.
Publicado: (2023)

The phenotype of CD3–CD56(bright) and CD3–CD56(dim) natural killer cells in systemic lupus erythematosus patients and its relation to disease activity
por: Soelistyoningsih, Dwi, et al.
Publicado: (2022)

Three Dimensional Cell Culturing for Modeling Adrenal and Pituitary Tumors
por: Krokker, Lilla, et al.
Publicado: (2021)

Growth Pattern and Prognostic Factors of Untreated Nonfunctioning Pituitary Adenomas
por: Hwang, Kihwan, et al.
Publicado: (2019)

Neuroendoscopic and microscopic transsphenoidal approach for resection of nonfunctional pituitary adenomas
por: Ding, Zhi-Quan, et al.
Publicado: (2019)

Heart Rate Variability in Postoperative Patients with Nonfunctioning Pituitary Adenoma
por: Ha, Jeonghoon, et al.
Publicado: (2021)

Treatment of Postsurgical Clinically Nonfunctioning Pituitary Adenomas Remnants With Cabergoline
por: Vieira, Marina C M, et al.
Publicado: (2021)

Serum ferritin as a risk factor for type 2 diabetes mellitus, regulated by liver transferrin receptor 2
por: Zhang, Rui, et al.
Publicado: (2021)

ODP339 Nonfunctioning Giant Adenomas
por: Oliveira, Miriam C, et al.
Publicado: (2022)

Human CD56(dim)CD16(dim) Cells As an Individualized Natural Killer Cell Subset
por: Amand, Mathieu, et al.
Publicado: (2017)

CD56 Is a Pathogen Recognition Receptor on Human Natural Killer Cells
por: Ziegler, Sabrina, et al.
Publicado: (2017)

Clinical features and management of nonfunctioning giant pituitary adenomas causing hydrocephalus
por: Zhang, Danfeng, et al.
Publicado: (2018)

Stratifying nonfunctional pituitary adenomas into two groups distinguished by macrophage subtypes
por: Yagnik, Garima, et al.
Publicado: (2019)

Free Mucosal Graft for Reconstruction after Nonfunctional Pituitary Adenoma Surgery
por: Pérez-López, Carlos, et al.
Publicado: (2020)

Changes in vascular supply pattern associated with growth of nonfunctioning pituitary adenomas
por: Ito, Miiko, et al.
Publicado: (2022)

Alterations of the Gut Microbiome in Patients With Pituitary Adenoma
por: Hu, Jinxian, et al.
Publicado: (2022)

Human Circulating and Tissue-Resident CD56(bright) Natural Killer Cell Populations
por: Melsen, Janine E., et al.
Publicado: (2016)

Correction: Stratifying nonfunctional pituitary adenomas into two groups distinguished by macrophage subtypes
por: Yagnik, Garima, et al.
Publicado: (2019)

BRD4 as a therapeutic target for nonfunctioning and growth hormone pituitary adenoma
por: Shi, Chengzhang, et al.
Publicado: (2020)

Management after initial surgery of nonfunctioning pituitary adenoma: surveillance, radiotherapy or surgery?
por: Charleux, Thomas, et al.
Publicado: (2022)

Metabolic Characteristics and M2 Macrophage Infiltrates in Invasive Nonfunctioning Pituitary Adenomas
por: Lin, Kunzhe, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n3sm1q5k6htre7je5053lgipri